NewsRx

Search our medical news database

Contraception

New low-dose Ortho Tri-Cyclen approved by FDA

Published in Women's Health Weekly, October 3rd, 2002

The U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive, Ortho Tri-Cyclen Lo (norgestimate/ethinyl estradiol) Tablets for the prevention of pregnancy. Ortho Tri-Cyclen Lo will be available by prescription in the fall.

Like other oral contraceptives, Ortho Tri-Cyclen Lo, is highly effective when taken correctly. It contains a combination of hormones - estrogen and the progestin norgestimate.

Ortho Tri-Cyclen Lo was developed by Ortho-McNeil Pharmaceutical, Inc.

"Ortho Tri-Cyclen Lo is an important new option in birth control, and one that I believe women will be excited about," said Ronald T. Burkman,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook